David A. Siegel Insmed Inc Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Insmed Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 295,400 shares of INSM stock, worth $21.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
295,400
Previous 716,400
58.77%
Holding current value
$21.4 Million
Previous $19.4 Million
1.83%
% of portfolio
0.05%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding INSM
# of Institutions
447Shares Held
170MCall Options Held
5.79MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA16MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.03 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$882 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$425 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$338 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.82B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...